Medtronic Diabetes is voluntarily recalling Quick-set® infusion sets that have lot numbers starting with the number “8”. These infusion sets are used with MiniMed Paradigm® Insulin Pumps. The action was taken because of a situation related to the tubing connector which may not allow the insulin pump to vent properly. …

The American Society of Metabolic and Bariatric Surgery met last week and released new information — be sure to check out this week’s Items 12 through 15. You have seen the backlash from the recent studies on Lantus and Cancer and already other insulin manufacturers are touting their products for …

…who has been in private practice for over 20 years, is telling his patients, “When the articles came out, the American Diabetes Association commented…”

“Just when those of us in the diabetes community have been riding a wave of reassurance from very recent studies showing favorable rosiglitazone safety results, comes word of studies published in the current issue of Diabetalogia raising the question as to whether insulin glargine (Lantus) may be associated with an increased …

“I have had at least 50 phone calls this weekend — all of the patients want to know what to do….”

POSSIBLE LINK BETWEEN INSULIN GLARGINE AND CANCER QUESTIONED –  MORE RESEARCH REQUIRED Experts stress patients should not stop using insulin and consult their doctor if concerned.  See This Week’s Item 1 Takeda’s Diabetes Drug Alogliptin Rejected by FDA  Asia’s biggest drugmaker, Takeda, failed to gain U.S. regulatory approval to market …

EXTRA – SPECIAL JULY 6th EDITION:  Top Clinicians Share Lantus Guidance  Click here for the inside stories…   Lantus Cancer Concern Inconclusive Details of a new study, “Lantus insulin: a possible link with cancer which requires further investigation,”to be published in the Journal of the EASD, “Diabetologia,” have been leaked. This …

Mothers who drink an excessive amount of fructose-sweetened beverages during pregnancy or breast-feeding may be likelier to have children—at least sons—who are more prone to becoming overweight and developing Type 2 diabetes, authors of a new study reported.

Just as in the Accord study and in the Avandia debacle controversy, premature release of this kind of information before all the facts are in can be devastating for the medical community and patients. They will tell patients to consult with their physicans before making any changes to their treatment. …

Researchers studying 6,538 people in the UK over almost 10 years found specific changes in blood glucose levels and sensitivity to the hormone insulin.